Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. - Wikidata - wikimedia - TriplyDB

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.

http://www.wikidata.org/entity/Q37360176

about

Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention Circulating tumor cells in breast cancer: a tool whose time has come of age Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients Circulating tumor cells: approaches to isolation and characterization The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells Stem cell technology in breast cancer: current status and potential applications Cancer stem cells (CSCs), cervical CSCs and targeted therapies Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Interaction between circulating cancer cells and platelets: clinical implication Circulating cancer stem cells: the importance to select Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?A Quantitative Perspective on Surface Marker Selection for the Isolation of Functional Tumor Cells Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers Bone metastases: When and how lung cancer interacts with bone Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma Metastatic cancer stem cells: from the concept to therapeutics Dynamic changes in numbers and properties of circulating tumor cells and their potential applications Epithelial-mesenchymal plasticity in carcinoma metastasis Sheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transition Emerging technologies for CTC detection based on depletion of normal cells Minimal residual disease and circulating tumor cells in breast cancer Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research Progress in circulating tumor cell capture and analysis: implications for cancer management Circulating tumor cells in the diagnosis and management of pancreatic cancer Glucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cells Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack The Challenges of Detecting Circulating Tumor Cells in Sarcoma AKT-ions with a TWIST between EMT and MET Concise Review: Stem Cells in Pancreatic Cancer: From Concept to Translation EMT, CTCs and CSCs in tumor relapse and drug-resistance Using circulating tumor cells to inform on prostate cancer biology and clinical utility Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3?CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis The Regulatory Role of MicroRNAs in EMT and Cancer Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines Molecular biomarker analyses using circulating tumor cells Label-free single-cell separation and imaging of cancer cells using an integrated microfluidic system.

P2860

Q21129293-6953D8A0-2DFF-4E53-9A52-499F00832F9A Q21245253-E7969167-A3A1-4911-96D0-0F87A8C5A790 Q21284707-F820107A-32B0-44FE-9ADF-9B368D7E6E48 Q24631347-91627BC2-55B2-464A-9116-2C5998F3D9F6 Q26741223-3E0CEE96-9D1F-477C-AFE4-4A69B5CA6043 Q26746223-A62EAC76-0ADA-4761-A3FD-DB4A4810C7A0 Q26747144-3451CBC1-827E-4545-A113-0F1EAF5D85ED Q26748850-09A2093D-CBF2-4E00-A367-13038EA3AFFE Q26778920-B8B2284C-6E40-436E-8203-1D074554DA6D Q26778924-2E757BE4-92F5-4636-8AA0-08470612BD6B Q26786476-5058A3E0-0531-4790-8F72-4D292783D0E1 Q26796595-7825DA92-CD63-4583-89D1-143A143A52AE Q26797232-43B9288B-A755-4C49-A8D4-4B8DC6D1BDE1 Q26822406-010C779B-A9C4-4CF5-820F-AFD7BEBED624 Q26823287-4760A422-FD8C-42AF-8162-0F8EC63672E8 Q26849546-C3821EC8-1833-4EE2-80DC-9CD0FADA4CA1 Q26850739-E4572C3F-04A8-466B-B35B-C2974B669699 Q26853569-9C2500F8-32E8-46F3-ADBC-FB2B7777C2CF Q26859804-63DD4615-1F5C-489E-A34F-1C04A541288D Q26864979-A7A3CF81-61A7-41BB-8007-E66AD4BB683C Q27009519-64AB05C2-E0D3-475B-BB2A-3FB9D69B79B5 Q27010152-9CEBEF6E-5B5A-4216-A608-BCCD0DD20E2D Q27024191-D11D1BE5-588E-4437-BB97-357D4658829A Q27025737-51110CED-FB6D-4A5F-A554-5110F8CAC6C3 Q27027711-7B0FC399-4D6B-4D0C-895B-70D37FC67F34 Q27345982-886C23A9-4626-4645-BB03-67A9E09DF8D8 Q28066285-3A9DF0F7-0878-4913-A9E1-DB85F884C928 Q28067549-212C8D9F-DC8D-4129-BC17-3392E95A6291 Q28078659-EC51BD7C-C0CA-406C-9A5D-21E8EE011687 Q28078987-BD2E5C89-069C-4218-AB86-85C384A3BD3D Q28081553-5376233F-8275-4B45-9803-5CEA04C07FD0 Q28082935-B714B625-3AFE-4CFE-999A-961E3B67AA0E Q28083261-6F3A977F-E4B1-47F8-B4EF-D46B28E0C34C Q28087055-4B735892-A7B1-4EF2-894B-4B4981CE91AE Q28250164-8EC3E0A1-C0C8-418B-AC48-1A9B7E9C926F Q28388257-FF43AC76-E10C-4717-B49A-01EC98D443A0 Q28391426-2D06903B-F643-4E1B-A25E-AC11CC50B203 Q28483475-1ADC3374-B4AD-43AD-81AE-DD6FD350CE6F Q28749394-9CE75665-204C-4352-AA50-F28E55A14020 Q30358279-DE321FDC-05CC-472F-B770-A7E61C7C7142

P2860

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.

http://www.wikidata.org/entity/Q37360176

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Stem cell and epithelial-mesen ...... static breast cancer patients.

@en

Stem cell and epithelial-mesen ...... static breast cancer patients.

@nl

type

label

Stem cell and epithelial-mesen ...... static breast cancer patients.

@en

Stem cell and epithelial-mesen ...... static breast cancer patients.

@nl

prefLabel

Stem cell and epithelial-mesen ...... static breast cancer patients.

@en

Stem cell and epithelial-mesen ...... static breast cancer patients.

@nl

P1433

Q37360176-F4EA1347-FA4E-4001-965B-97CD154CAB59

P1476

Q37360176-A9C23E13-67DE-47EF-87DD-8E48174D86ED

P2093

Q37360176-1F465E92-EF78-43F6-ABCB-8DCF076F0F2C

Q37360176-AB222A8A-572D-4F0C-BE09-09EE0640B99A

Q37360176-F5F9DF24-B45E-4A29-BC49-C7A3CA3BFF65

P2860

Q37360176-0027C627-95D1-4C2B-9E05-2D39A325CAD0

Q37360176-01B3C44C-B252-4100-968C-8BD69D432857

Q37360176-0F25A441-D0D5-42AB-871A-0DC746FE6317

Q37360176-226FE47D-066D-45FC-BB01-7EA2F0E76FAE

Q37360176-29561DAE-771D-4AFE-B6ED-84BA954C9EAD

Q37360176-2BC45A33-226E-4F1E-8490-262CAF976209

Q37360176-31F8664D-C8DD-4BEF-ADC8-BF14B6A5766C

Q37360176-333BF55B-2724-4CE1-9455-528F3FEF13B4

Q37360176-33C155CA-1E64-470C-BEF5-F744975A77D3

Q37360176-3C124A5C-A7DD-4496-BDA8-8582AF8AB211

P2888

Q37360176-EBA75D69-3DCC-4DB5-9416-E7452796583A

P304

Q37360176-D57C70C5-F041-4973-ACFD-1BFDAF76A61D

P31

Q37360176-65539064-A42E-42E8-8C22-AC7941FC5583

P356

Q37360176-F87059A4-E220-4DB0-8046-C9CD7A6FE99A

P433

Q37360176-3BCCC8E6-1805-4206-88AE-EB174D7466B8

P478

Q37360176-F2CFBE62-5E41-4851-8719-A9CD0694454B

P50

Q37360176-072D86F6-E6F2-4A1A-BB5E-C5B109417CC6

Q37360176-6A857C7D-0FF6-4332-9E35-45238F823B66

Q37360176-8BD1D818-D4F8-4E0E-B382-BEA5F2CC792B

P577

Q37360176-9675F0D8-CBA8-43AB-8F4B-8C150C005F89

P5875

Q37360176-C568EB3E-0937-488A-8556-784B5FE14C1A

P6179

Q37360176-5EB341A0-9F9C-424C-9F1D-EFDA3E72EE4F

P698

Q37360176-38DBEBBC-21AB-476A-857A-4129CCD728C4

P921

Q37360176-1B8C1823-2202-4654-A40E-1CAF618D172F

Q37360176-323159A6-73B7-4DED-A7F1-A52783B910C1

P932

Q37360176-30E5B3C1-F0A3-4D3D-8A69-B9BB0B946A2C

P356

P1433

Breast Cancer Research

P1476

Stem cell and epithelial-mesen ...... static breast cancer patients.

@en

P2093

Mitra Tewes

http://www.w3.org/2001/XMLSchema#string

Rainer Kimmig

http://www.w3.org/2001/XMLSchema#string

Siegfried Hauch

http://www.w3.org/2001/XMLSchema#string

P2860

Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers

Prospective identification of tumorigenic breast cancer cells

Akt2: a role in breast cancer metastasis

Epithelial-mesenchymal transitions in tumour progression

Molecular definition of breast tumor heterogeneity

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

Systemic spread is an early step in breast cancer

Phosphoinositide 3-kinase signalling pathways.

P2888

P304

R46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2333

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Sabine Kasimir-Bauer

P577

2009-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26658260

http://www.w3.org/2001/XMLSchema#string

P6179

1000606439

http://www.w3.org/2001/XMLSchema#string

P698

19589136

http://www.w3.org/2001/XMLSchema#string

P921

P932

2750105

http://www.w3.org/2001/XMLSchema#string